CN101514198B - 一种泮托拉唑钠化合物及其制法 - Google Patents
一种泮托拉唑钠化合物及其制法 Download PDFInfo
- Publication number
- CN101514198B CN101514198B CN200910019756XA CN200910019756A CN101514198B CN 101514198 B CN101514198 B CN 101514198B CN 200910019756X A CN200910019756X A CN 200910019756XA CN 200910019756 A CN200910019756 A CN 200910019756A CN 101514198 B CN101514198 B CN 101514198B
- Authority
- CN
- China
- Prior art keywords
- value
- making
- solid
- pantoprazole sodium
- adsorbent resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229960004048 pantoprazole sodium Drugs 0.000 title claims abstract description 33
- YNWDKZIIWCEDEE-UHFFFAOYSA-N pantoprazole sodium Chemical compound [Na+].COC1=CC=NC(CS(=O)C=2[N-]C3=CC=C(OC(F)F)C=C3N=2)=C1OC YNWDKZIIWCEDEE-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 150000001875 compounds Chemical class 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 30
- 239000007787 solid Substances 0.000 claims description 24
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 22
- 239000011347 resin Substances 0.000 claims description 20
- 229920005989 resin Polymers 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 239000003463 adsorbent Substances 0.000 claims description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- 230000001105 regulatory effect Effects 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical group ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 229960001701 chloroform Drugs 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- -1 hydrogen salt Chemical class 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 2
- 235000015320 potassium carbonate Nutrition 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 abstract description 6
- 229960005019 pantoprazole Drugs 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 4
- 238000009776 industrial production Methods 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 10
- 238000000746 purification Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 3
- 235000015424 sodium Nutrition 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 210000001711 oxyntic cell Anatomy 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- KYKNRZGSIGMXFH-UHFFFAOYSA-M potassium;2,3-dihydroxybutanedioate;hydron Chemical compound [K+].OC(=O)C(O)C(O)C([O-])=O KYKNRZGSIGMXFH-UHFFFAOYSA-M 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- NASFKTWZWDYFER-UHFFFAOYSA-N sodium;hydrate Chemical compound O.[Na] NASFKTWZWDYFER-UHFFFAOYSA-N 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000011003 system suitability test Methods 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910019756XA CN101514198B (zh) | 2009-03-31 | 2009-03-31 | 一种泮托拉唑钠化合物及其制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910019756XA CN101514198B (zh) | 2009-03-31 | 2009-03-31 | 一种泮托拉唑钠化合物及其制法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101514198A CN101514198A (zh) | 2009-08-26 |
CN101514198B true CN101514198B (zh) | 2012-06-20 |
Family
ID=41038830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910019756XA Expired - Fee Related CN101514198B (zh) | 2009-03-31 | 2009-03-31 | 一种泮托拉唑钠化合物及其制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101514198B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103012373B (zh) * | 2013-01-16 | 2014-11-05 | 湖北济生医药有限公司 | 一种泮托拉唑钠化合物及其药物组合物 |
CN104628704B (zh) * | 2015-02-12 | 2015-12-30 | 天津大学 | 一种泮托拉唑钠化合物的新晶型及其制备方法 |
CN104693179B (zh) * | 2015-02-12 | 2017-03-08 | 天津大学 | 泮托拉唑钠化合物的新晶型及制备方法 |
CN104876910A (zh) * | 2015-05-26 | 2015-09-02 | 苗怡文 | 一种治疗胃病的药物泮托拉唑钠化合物及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1827089A (zh) * | 2005-02-28 | 2006-09-06 | 上海艾力斯医药科技有限公司 | 一种包含酸不稳定药物的微细颗粒及其制剂 |
CN101305995A (zh) * | 2007-05-17 | 2008-11-19 | 北京利乐生制药科技有限公司 | 一种含有多潘立酮泮托拉唑钠的缓释制剂及其制备方法 |
-
2009
- 2009-03-31 CN CN200910019756XA patent/CN101514198B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1827089A (zh) * | 2005-02-28 | 2006-09-06 | 上海艾力斯医药科技有限公司 | 一种包含酸不稳定药物的微细颗粒及其制剂 |
CN101305995A (zh) * | 2007-05-17 | 2008-11-19 | 北京利乐生制药科技有限公司 | 一种含有多潘立酮泮托拉唑钠的缓释制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101514198A (zh) | 2009-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101704811B (zh) | 一种高纯度的雷贝拉唑钠化合物 | |
CN101514198B (zh) | 一种泮托拉唑钠化合物及其制法 | |
CN111763703B (zh) | 一种有机溶剂中酶法合成蔗糖-6-乙酯的方法 | |
CN102304554B (zh) | 一种高色价栀子红色素的生产方法 | |
CN101514199B (zh) | 一种兰索拉唑化合物及其制法 | |
US9308216B2 (en) | Rutin-rich extract and method of making same | |
CN115152927B (zh) | 一种紫玉米花色苷复合物及其制备方法 | |
CN102706997B (zh) | 盐酸法舒地尔有关物质的检测方法 | |
CN102372726A (zh) | 西罗莫司粗晶的制备方法 | |
CN102993251B (zh) | 一种用高效液相色谱纯化台勾霉素b的方法 | |
CN101696212B (zh) | 一种高纯度的他唑巴坦钠化合物 | |
CN106831804A (zh) | 离子交换和硅胶柱层析法分离制备汉防己甲、乙素的方法 | |
CN104231016A (zh) | 一种硫酸依替米星的制备方法 | |
CN103601624A (zh) | 一种超纯丙酮的制备方法 | |
CN101696211B (zh) | 一种高纯度的舒巴坦钠化合物 | |
CN102863517B (zh) | 一种戈舍瑞林的纯化方法 | |
CN101412710B (zh) | 一种奥美拉唑钠化合物及其制法 | |
CN106561722A (zh) | 裙带菜的抑藻用途及裙带菜抑藻活性物质的分离纯化方法 | |
CN102329301B (zh) | 一种埃索美拉唑钠化合物及其制法 | |
CN108707148A (zh) | 一种消旋山莨菪碱中四个异构体的手性拆分方法 | |
CN102557980B (zh) | 结晶制备高纯辣椒碱单体的方法 | |
CN103613601A (zh) | 硫取代鬼臼毒素类衍生物及其合成方法和应用 | |
CN114028346B (zh) | 注射用奥美拉唑钠及其制备方法 | |
CN103421062A (zh) | 一种紫穗槐苷的制备方法 | |
CN106146531A (zh) | 一种高纯度米尔贝霉素的生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN LINGKANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHANG XIFEN Effective date: 20130717 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310052 HANGZHOU, ZHEJIANG PROVINCE TO: 570216 HAIKOU, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130717 Address after: 570216 Hainan Province, Haikou city Jinpan Industrial Development Zone Industrial Village No. 3-6 building Patentee after: Hainan Lingkang Pharmaceutical Co., Ltd. Address before: 310052, Zhejiang, Hangzhou province Binjiang District foreshore road watermark city 3, room 1602 Patentee before: Zhang Xifen |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120620 Termination date: 20170331 |
|
CF01 | Termination of patent right due to non-payment of annual fee |